Photomedicine-based
antimicrobial therapy has emerged as an alternative
treatment for antibiotic-resistant microbial infections. Although
various photosensitizers (PSs) have been reported as efficient antimicrobial
agents, their efficient delivery to the specific target area requires
further investigation. In the current study, development of a biodegradable
phototheranostic nanoagent (PTNA) by incorporation of a PS (trans-AB-porphyrin) and gelatin nanomatrix is described.
The antimicrobial efficacy of the PTNA against Gram-positive bacteria,
Gram-negative bacteria, and yeast strains, along with other properties
including hydrophilicity, biocompatibility, and targeting ability,
is evaluated. Unlike the commonly used membrane permeabilizing chemicals
that are toxic, the delivery vehicle gelatin used in this study is
biocompatible and biodegradable. Here, the method offers a sustainable
synthesis of gelatin-based stable formulation of nanotheranostic agents
with high loading (>85%). The study revealed that the reactive
oxygen
species (ROS), generated in situ by the PTNAs, are primarily responsible
for microbial cell death. The developed PTNAs described herein featured
“nano size (<200 nm), have high fluorescence and singlet
oxygen quantum yields, retain photophysical properties of PS after
incorporation into the gelatin matrix, could be activated by a cost-effective
light irradiation, and have efficient antimicrobial photodynamic activity.”
This antimicrobial photodynamic therapy using the newly synthesized
phototheranostic nanoagent has manifested its competence, therapeutic
modality of general acceptance, and wide-spectrum antimicrobial action.